HEM:CC Message Board Post 7279244 | Hemostemix Inc.
home / stock / hem:cc / hem:cc message board
royjame8765
Member
Posted on: Apr/19/2023 07:23:43
Source: mwn
Hemostemix Inc. (TSXV: $HEM) has significant long-term growth potential and is an appealing option for investors seeking exposure to the biotechnology sector. The company is well-positioned to capitalise on the increasing demand for cell-based therapies and the potential market opportunity. The stock was previously trading at $0.165, with 81,089,626 listed shares outstanding.
News, Short Squeeze, Breakout and More Instantly...
-
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
-
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
-
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...